期刊文献+

冠心病患者血清胱抑素C和胆红素测定及其临床意义 被引量:2

Cystatin c and bilirubin changes and its clinical significance in patients with CHD
暂未订购
导出
摘要 目的:探讨血清胱抑素C和胆红素在冠心病患者中的含量以及对评估冠心病病情的临床意义。方法:将320例经冠状动脉造影证实为冠心病的患者根据病变冠脉支数的不同分为单支病变组128例,双支病变组110例和多支病变组82例,对照组80例为冠脉正常者,测定各组血清胱抑素C、胆红素以及血脂水平。结果:从对照组到多支病变组,随着病变冠脉支数的增多,血清胱抑素C含量,血脂TC、TG、LDL-C出现不同程度的升高(P<0.05);血清胆红素、HDL-C则出现明显的下降(P<0.05)。结论:血清胱抑素C和胆红素可以作为评估冠状动脉粥样硬化严重程度的敏感指标,指导临床诊断和治疗。 Objective: To detective the clinical significance of serum cystatin C and bilirubin levels in pa tients with coronary heart disease. Methods: 320 cases CHD divided into 3 groups based on different lesions in coro nary count, 128 cases in single-vessel disease group, 110 cases in double-vessel disease group and 82 cases in multi- vessel disease group. The control group had 80 cases with normal coronary. Determined the serum cystatin C, bill rubin, and lipid levels. Results: From the control group to multi-vessel disease group, with the coronary lesion count increase, serum cystatin C levels, TC, TG and LDL-C increased significantly; serum bilirubin, HDL-C de creased significantly. Conclusion : Serum cystatin C and bilirubin can be used to assess the severity of coronary ather osclerosis as a sensitive indicators.
出处 《陕西医学杂志》 CAS 2014年第1期60-62,共3页 Shaanxi Medical Journal
关键词 冠状动脉疾病 诊断 胆红素 代谢蛋白质类 代谢@血清胱抑素c Coronary disease/diagnosis Bilirubin/matablism Proteins/matablism @Cystatin C
  • 相关文献

参考文献7

  • 1Gaziano TA. Cardiovascular disease in the developing world and its costeffective management[J]. Circulation, 2005,112(23) : 3547-3553.
  • 2Tsai HT, Wang PH, Tee YT, et al. Imbalanced ser- um concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease [J]. Fertility and sterility, 2009, 91(2): 549 -555.
  • 3Bengtsson E, To F, Grubb A, etal. Absence of the pro- tease inhibitor eystatin C in inflammatory cells results in larger plaque area in plaque regression of apo E-deficient mice[J]. Atherosclerosis, 2005,180(1):. 45-53.
  • 4Ix JH, Shlipak MG, Chertow GM, etal. Association of cystatin C with mortality, cardiovascular events, and in- cident heart failure among persons with coronary heart disease data from the heart and soul study[J]. Cireula tion, 2007,115(2): 173-179.
  • 5Sukhova, GK, Wang B, Libby P, et al. Cystatin C defi ciency increases elastic lamina degradation and aortic dila tation in apolipoprotein E-null mice[J]. Circulation Re search, 2005,96(3): 368- 375.
  • 6韩翰,李佳,王岚峰.胆红素在冠心病发病过程中的保护作用[J].中华老年心脑血管病杂志,2012,14(9):995-997. 被引量:16
  • 7Schwerther HA, Jackson WG, Tolan G, et al. Associa tion of low serum concentration of bilirubin with in creased risk of coronary artery disease [J]. Clinical Chemistry, 1994,40(1): 18- 23.

二级参考文献20

  • 1Wang CY,Chau LY. Heme oxygenase 1 in cardiovascular dis- eases:Molecular mechanisms and clinical perspectives. Chang Gung Medical Journal,2010,33 : 13 24.
  • 2Dulak J, Deshane J, Jozkowicz A, et al. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: Focus on angio- genesis. Circulation, 2008,117 : 231-241.
  • 3Wu ML, Ho YC, Yet SF. A central role of heine oxygenase-1 in cardiovascular protection. Antioxid Redox Signal, 2011,15: 1835-1846.
  • 4Ollinger R, Bilban M, Erat A, et al. Bilirubin : A natural inhibi- tor of vascular smooth muscle cell proliferation. Circulation, 2005,112 : 1030-1039.
  • 5Kuwano T, Miura S, Shirai K, et al. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: A new look at an old molecule. J Atheroscler Thromb, 2011,18: 574-583.
  • 6Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C reactive protein. Clin Chem Lab Med, 2011,49: 1823- 1828.
  • 7Gullu H,Erdogan D,Tok D, et al. High serum bilirubin con- centrations preserve coronary flow reserve and coronary mi- crovascular functions. Arterioscer Thromb Vasc Biol, 2005, 25 : 2289-2294.
  • 8McCarty MF. Iatrogenic Gilbert syndrome: A strategy for re- ducing vascular and cancer risk by increasing plasma uneonju- gated bilirubin. Med Hypotheses, 2007,69 : 974-994.
  • 9Abraham NG,Kappas A. Pharmacological and clinical aspects of hemo oxygenase. Pharmacol Rev, 2008,60 : 79-127.
  • 10Maghzal GJ ,Leck MC,Collinson E,et al. Limited role for the bilirubin biliverdin redox amplification cycle in the cellular an- tioxidant protection by biliverdin reduetase. J Biol Chem, 2009,284 : 29251-29259.

共引文献15

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部